Invesco S&P SmallCap Health Care ETF (PSCH)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Invesco S&P SmallCap Health Care ETF (PSCH) with AI Score 44/100 (Weak). The Invesco S&P SmallCap Health Care ETF seeks to replicate the performance of the S&P SmallCap 600 Capped Health Care Index. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 17, 2026Invesco S&P SmallCap Health Care ETF (PSCH) Financial Services Profile
Invesco S&P SmallCap Health Care ETF (PSCH) provides targeted exposure to the US small-cap healthcare sector by mirroring the S&P SmallCap 600 Capped Health Care Index, offering investors a focused investment vehicle within the broader financial services landscape, with a market cap of $0.15B.
Investment Thesis
The Invesco S&P SmallCap Health Care ETF (PSCH) presents a targeted investment opportunity within the small-cap healthcare sector. With a beta of 1.17, the fund exhibits slightly higher volatility compared to the broader market. PSCH's value is driven by the performance of the S&P SmallCap 600 Capped Health Care Index, reflecting the collective success of its constituent companies. Growth catalysts include advancements in healthcare technology, favorable regulatory changes, and increased healthcare spending. However, potential risks include regulatory hurdles, clinical trial failures, and market downturns affecting small-cap stocks. Investors may want to evaluate the fund's focused exposure and inherent volatility when evaluating its suitability for their portfolios. The ETF does not offer a dividend yield.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.15 billion, indicating a small-cap fund focused on the healthcare sector.
- Beta of 1.17, suggesting slightly higher volatility compared to the broader market.
- Invests at least 90% of its assets in securities comprising the S&P SmallCap 600 Capped Health Care Index.
- Offers targeted exposure to small-cap US healthcare companies.
- Rebalanced and reconstituted quarterly to maintain alignment with the underlying index.
Competitors & Peers
Strengths
- Targeted exposure to the small-cap healthcare sector.
- Diversified portfolio of healthcare stocks.
- Transparent and rules-based investment approach.
- Low expense ratio compared to actively managed funds.
Weaknesses
- Concentrated exposure to a single sector.
- Vulnerability to market downturns affecting small-cap stocks.
- Dependent on the performance of the S&P SmallCap 600 Capped Health Care Index.
- No dividend yield.
Catalysts
- Upcoming: Quarterly rebalancing and reconstitution of the S&P SmallCap 600 Capped Health Care Index.
- Ongoing: Advancements in medical technology and healthcare innovation.
- Ongoing: Favorable regulatory changes promoting healthcare growth.
Risks
- Potential: Regulatory hurdles and clinical trial failures.
- Potential: Market downturns affecting small-cap stocks.
- Ongoing: Competition from other healthcare ETFs and investment vehicles.
Growth Opportunities
- Increased Healthcare Spending: The aging global population and rising prevalence of chronic diseases are driving increased healthcare spending worldwide. This trend benefits small-cap healthcare companies focused on innovative treatments, diagnostic tools and healthcare services. PSCH is positioned to capitalize on this growth as it invests in these companies. The global healthcare expenditure is projected to reach over $10 trillion by 2026, creating a substantial market opportunity for PSCH's holdings.
- Technological Advancements: Rapid advancements in medical technology, including telemedicine, AI-powered diagnostics, and robotic surgery, are transforming the healthcare landscape. Small-cap companies are often at the forefront of these innovations, offering high-growth potential. PSCH's investment in these companies allows investors to gain exposure to these technological breakthroughs. The market for AI in healthcare alone is expected to reach $34 billion by 2026.
- Favorable Regulatory Environment: Government initiatives and regulatory changes aimed at promoting healthcare innovation and access can create a favorable environment for small-cap healthcare companies. Streamlined approval processes for new drugs and medical devices can accelerate growth and profitability. PSCH benefits from these regulatory tailwinds, as its holdings are well-positioned to capitalize on these opportunities. Ongoing regulatory reforms are expected to further boost the healthcare sector.
- Mergers and Acquisitions: The healthcare industry is characterized by ongoing consolidation, with larger companies acquiring smaller, innovative firms. This trend can lead to significant gains for PSCH, as its holdings may become attractive acquisition targets. The ETF's exposure to small-cap companies positions it to benefit from this M&A activity. The total value of healthcare M&A deals is projected to exceed $500 billion in 2026.
- Emerging Markets Expansion: As emerging markets experience economic growth and improved healthcare infrastructure, demand for healthcare products and services is increasing. Small-cap healthcare companies are expanding their presence in these markets, creating new growth opportunities. PSCH's investment in these companies allows investors to participate in this global expansion. The emerging markets healthcare sector is expected to grow at a rate of 10% annually over the next five years.
Opportunities
- Increased healthcare spending driven by aging population.
- Technological advancements in the healthcare industry.
- Favorable regulatory environment for healthcare innovation.
- Mergers and acquisitions activity in the healthcare sector.
Threats
- Regulatory changes impacting the healthcare industry.
- Clinical trial failures affecting portfolio companies.
- Economic downturns reducing healthcare spending.
- Competition from other healthcare ETFs and mutual funds.
Competitive Advantages
- Index Tracking: PSCH benefits from tracking a well-established index, providing a transparent and rules-based investment approach.
- Brand Recognition: Invesco is a well-known and respected brand in the asset management industry, attracting investors to its ETFs.
- Low Cost: The ETF offers a relatively low expense ratio compared to actively managed healthcare funds.
About PSCH
The Invesco S&P SmallCap Health Care ETF (PSCH) is designed to track the performance of the S&P SmallCap 600 Capped Health Care Index. Launched by Invesco, a leading global investment management firm, the fund provides investors with a focused approach to investing in the healthcare sector. PSCH invests at least 90% of its total assets in securities that comprise the Index, offering a concentrated exposure to small-capitalization healthcare companies within the United States. These companies are principally engaged in providing healthcare-related products, facilities, and services, including biotechnology, pharmaceuticals, medical technology, and healthcare supplies. The Index itself is a subset of the broader S&P SmallCap 600 Index, which represents the US small-cap market. The ETF is rebalanced and reconstituted quarterly to maintain alignment with the index. As of 2026, PSCH continues to offer investors a way to participate in the growth potential of smaller healthcare companies, with a market capitalization of $0.15 billion.
What They Do
- Tracks the performance of the S&P SmallCap 600 Capped Health Care Index.
- Invests primarily in small-cap US healthcare companies.
- Provides targeted exposure to the healthcare sector.
- Offers a diversified portfolio of healthcare stocks.
- Rebalances and reconstitutes its holdings quarterly.
- Aims to replicate the index's performance before fees and expenses.
- Provides investors with a convenient way to access the small-cap healthcare market.
Business Model
- Generates revenue through management fees charged to investors.
- Aims to replicate the performance of the S&P SmallCap 600 Capped Health Care Index.
- Attracts investors seeking targeted exposure to the small-cap healthcare sector.
Industry Context
The Invesco S&P SmallCap Health Care ETF (PSCH) operates within the asset management industry, specifically focusing on the healthcare sector. The healthcare industry is characterized by constant innovation, regulatory oversight, and evolving patient needs. The ETF competes with other healthcare-focused ETFs and mutual funds, offering a specific focus on small-cap companies. The broader asset management industry is experiencing growth driven by increasing investor demand for specialized investment products. PSCH's focus on small-cap healthcare companies differentiates it within this competitive landscape.
Key Customers
- Individual investors seeking healthcare exposure.
- Institutional investors looking for diversified healthcare investments.
- Financial advisors seeking to allocate client portfolios to the healthcare sector.
Financials
Chart & Info
Invesco S&P SmallCap Health Care ETF (PSCH) stock price: Price data unavailable
Latest News
-
RadNet Makes $270 Million Bet On AI Future With Gleamer Buyout
benzinga · Mar 2, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PSCH.
Price Targets
Wall Street price target analysis for PSCH.
MoonshotScore
What does this score mean?
The MoonshotScore rates PSCH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
PSCH Financial Services Stock FAQ
What does Invesco S&P SmallCap Health Care ETF do?
The Invesco S&P SmallCap Health Care ETF (PSCH) is designed to mirror the performance of the S&P SmallCap 600 Capped Health Care Index. It provides investors with targeted exposure to the US small-cap healthcare sector, encompassing companies involved in biotechnology, pharmaceuticals, medical technology, and healthcare services. The fund invests at least 90% of its total assets in the securities that comprise the Index, offering a diversified portfolio of healthcare stocks within the small-cap segment. PSCH's business model revolves around providing a convenient and cost-effective way for investors to access this specific market segment.
What do analysts say about PSCH stock?
AI analysis is pending for PSCH. Generally, analysts may evaluate PSCH based on the growth prospects of the small-cap healthcare sector, the fund's expense ratio, and its tracking accuracy relative to the S&P SmallCap 600 Capped Health Care Index. Key valuation metrics would include the price-to-earnings ratio of the underlying holdings and the fund's net asset value. Growth considerations would focus on the potential for innovation and regulatory changes within the healthcare industry. The fund's beta of 1.17 indicates a slightly higher volatility compared to the broader market.
What are the main risks for PSCH?
The main risks for PSCH include regulatory changes impacting the healthcare industry, clinical trial failures affecting portfolio companies, and market downturns disproportionately affecting small-cap stocks. The fund's concentrated exposure to the healthcare sector makes it vulnerable to sector-specific risks. Additionally, competition from other healthcare ETFs and investment vehicles could impact PSCH's market share. Investors should also consider the fund's beta of 1.17, which indicates a slightly higher volatility compared to the broader market. These factors can influence the fund's performance and overall investment risk.
What are the key factors to evaluate for PSCH?
Invesco S&P SmallCap Health Care ETF (PSCH) currently holds an AI score of 44/100, indicating low score. Key strength: Targeted exposure to the small-cap healthcare sector.. Primary risk to monitor: Potential: Regulatory hurdles and clinical trial failures.. This is not financial advice.
How frequently does PSCH data refresh on this page?
PSCH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven PSCH's recent stock price performance?
Recent price movement in Invesco S&P SmallCap Health Care ETF (PSCH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Targeted exposure to the small-cap healthcare sector.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider PSCH overvalued or undervalued right now?
Determining whether Invesco S&P SmallCap Health Care ETF (PSCH) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying PSCH?
Before investing in Invesco S&P SmallCap Health Care ETF (PSCH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- AI analysis is pending and may provide further insights.